
M Power Education Records Explosive Growth During the COVID-19 Pandemic
By
Ivana Shuck
|
Frederick, MD (March 17, 2021) – M Power Education, a Frederick-based e-learning and career training company, has experienced an explosive growth in the past year, despite the global pandemic. The company grew from three to fifteen employees and expanded their client base as well as student enrollment – they have 7x more students enrolling in their … Read more
Veralox Therapeutics Announces FDA Orphan Drug Designation for VLX-1005
By
Jeff Strovel
|
FREDERICK, Md – January 26, 2021 – Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for VLX-1005 for the treatment of heparin induced thrombocytopenia (HIT). “We are pleased … Read more
Veralox Therapeutics Announces IND Submission for VLX-1005 to Treat Heparin-Inducted Thrombocytopenia
By
Jeff Strovel, Veralox CEO
|
FREDERICK, Md – January 12, 2021 – Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced it submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a Phase 1 clinical trial of VLX-1005, a … Read more
Nanoparticle COVID-19 vaccine REVC-128 potentially induces protection starting two weeks post prime by one dose
By
FITCI
|
Frederick, MD, November 2020 – ReVacc Biotech scientists have designed a multivalent nanoparticle vaccine candidate REVC-128 targeting the current predominant SARS-CoV-2 viral strain with D614G mutation. The preliminary immunogenicity study showed that REVC-128 induced ultrapotent neutralizing antibody titer at 14 days post prime, which suggests that their vaccine candidate has potential to induce protection starting two weeks … Read more
Trivance Design Launches Brand New Website
By
Thomas Stein, CEO, Trivance Design
|
Frederick, MD (October 2020) – Trivance Design, a Frederick-based 3D print shop has just announced the launch of their new friendly and easy-to-use website. The site provides information related to the process as well as capabilities of extrusion-based 3D printing that can help move client’s ideas into reality. “We were newbies to 3D printing when we dove into the Trivance Design … Read more
Leading the charge on ‘Know your Immunity,’ VirIntel, LLC announces a partnership with Clinical Diagnostic Laboratories (CDL)
By
Kim Gordon, VirInte
|
Frederick, MD (October, 2020 — VirIntel, LLC is excited to announce a partnership with Clinical Diagnostic Laboratories (CDL), one of the top Diagnostics Lab in the DC metro area, to offer the VirIntel COVID-19 Antibody Test available immediately. VirIntel leads the charge on the “know your immunity” movement in response to COVID-19 and has developed and commercialized a COVID-19 … Read more
NANOBIOFAB Awarded a $250,000 Defense Health Agency SBIR grant
Frederick, MD (September 2020) – Nanobiofab, a Frederick-based nanotechnology startup, was awarded a $250,000 Defense Health Agency (DHA) SBIR Program grant for their, “Inkjet assisted Nano printing sensing platform for high-throughput flexible sensors discovery” proposal.
By
Kathie Callahan Brady
|
Nanobiofab has worked continuously to meet the challenge of developing and manufacturing advanced sensing nanomaterials and equipment for the reliable fabrication of wearable and flexible sensors used in medical/health monitoring devices. This grant will be an immense help to Nanobiofab in future research. Nanosensors are creating new opportunities in medical simulation, wearable electronics, epidermal electronic … Read more
Veralox Therapeutics Appoints Life Sciences Industry Veteran Alex Martin as Chairman of the Board of Directors
By
Kathie Callahan Brady
|
FREDERICK, Md. (September, 2020) –Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the appointment of Alex Martin as Chairman of the Board of Directors. Mr. Martin brings to the Chairman’s role over 25 years of experience in senior executive roles … Read more
VirIntel launches VirIntel COVID-19 Antibody test, delivering superior accuracy
VirIntel, LLC is the R&D focused Immuno diagnostics startup located at the Frederick Innovation Technology Center pursuing the goal of immunity intelligence. VirIntel is leading the charge on the “know your immunity” movement in response to COVID-19.
By
Kim Gordon, VirIntel
|
About COVID-19 Testing at VirIntel VirIntel, LLC has developed and commercialized a COVID-19 antibody test with demonstrated 100% specificity and 94% sensitivity in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. The VirIntel COVID-19 Antibody Test measures antibodies against two viral proteins, a receptor-binding domain (RBD) of spike glycoprotein and nucleocapsid protein … Read more
CarrTech LLC Receives Its Fourth Patent and is Awarded $50,000 Grant by TEDCO
By
Kathie Callahan Brady
|
Frederick, MD, July, 2020 – CarrTech LLC has been awarded $50,000 from TEDCO’s Pre-seed Builder Fund, as well as professional executive coaching services for their leadership team. This significant investment and executive support specific to medical devices, will better position the company to receive follow-on, professional investment. It will assist them with the FDA approval application and establishing … Read more

